Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene US, LLC - The Rare Disease Company United States | 316 | 314 |
|
Centogene US, LLC - The Rare Disease Company United States | 289 | 275 |
|
Centogene US, LLC - The Rare Disease Company United States | 740 | 728 |
|
Centogene US, LLC - The Rare Disease Company United States | 829 | 848 |
|
Centogene US, LLC - The Rare Disease Company United States | 325 | 316 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
Centogene US, LLC - The Rare Disease Company United States | 777 | 770 |
|
FKTN - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 4 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
FKTN - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 165 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Rhabdomyolysis and Metabolic Myopathy Panel Invitae United States | 202 | 128 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.